UroLift is a minimally invasive treatment for benign prostatic hyperplasia (BPH), a condition where an enlarged prostate compresses the urethra, leading to urinary difficulties. Unlike traditional surgical methods, UroLift is a quick, outpatient procedure that uses small implants to lift and hold the prostate tissue away from the urethra, restoring normal urinary flow. While it’s an increasingly popular treatment, many men considering the procedure wonder: Is UroLift safe?

The answer is yes, UroLift has been extensively studied and is considered a safe and effective option for most men with BPH. Here’s a detailed look at the safety aspects of UroLift, including its risks, benefits, and how it compares to other treatments.

FDA Approval and Clinical Evidence 

UroLift was approved by the U.S. Food and Drug Administration (FDA) in 2013, following rigorous clinical trials to ensure its safety and efficacy. Since then, thousands of men worldwide have undergone the procedure with positive results. Clinical studies show that UroLift significantly improves urinary symptoms and quality of life while preserving sexual function, a key advantage over some other treatments for BPH.

How Safe Is the Procedure? 

Minimally Invasive Approach 

One of the reasons UroLift is considered safe is its minimally invasive nature. The procedure does not involve cutting, heating, or removing prostate tissue, which reduces the risk of complications. Instead, small implants are placed through the urethra to lift the prostate tissue away, leaving the surrounding structures unharmed.

Outpatient Procedure 

UroLift is typically performed in a doctor’s office or outpatient setting, often under local anesthesia. This eliminates the need for general anaesthesia, reducing risks associated with more invasive surgeries. Most patients can go home the same day and resume light activities within a few days.

Minimal Side Effects 

The side effects of UroLift are usually mild and temporary, making it a safer alternative to traditional surgical treatments like transurethral resection of the prostate (TURP). Common side effects include:

  • Mild discomfort during urination.
  • A slight burning sensation.
  • Blood in the urine or semen.
  • Increased urinary urgency or frequency.

These symptoms typically resolve within a few days to weeks as the body heals. Serious complications, such as infections or injury to surrounding tissues, are rare.

Comparison to Other Treatments 

Medications

Long-term use of BPH medications can lead to side effects such as dizziness, fatigue, or decreased libido. UroLift offers a one-time solution without the ongoing risks associated with medications.

Traditional Surgery

Procedures like TURP or laser surgery carry a higher risk of complications, including bleeding, infections, and sexual dysfunction. UroLift preserves sexual function and has a lower overall risk profile.

Who Is UroLift Safe For?

UroLift is generally safe for men with mild to moderate BPH who have prostates between 30 and 80 grams in size. It’s particularly suitable for those who want to avoid medications or more invasive surgeries. However, it may not be recommended for men with:

  • Large prostates exceeding 80 grams.
  • A significantly enlarged middle lobe of the prostate.
  • Active urinary tract infections or bladder stones.

Your urologist will evaluate your specific condition to determine if UroLift is the best option for you.

Conclusion 

UroLift is a safe, effective, and minimally invasive procedure for treating BPH. With minimal risks and a quick recovery, it has become a preferred choice for men seeking relief from urinary symptoms without compromising sexual function. If you’re considering UroLift, book your consultation with your doctor to discuss your unique health needs and determine if this procedure is right for you.